NMPA Approval

Irbesartan and Hydrochlorothiazide Tablets

Approval Number

国药准字J20130041

Registration Date

July 9, 2020

Previous Approval Numbers

H20140194H20140195

Drug Information

Generic Name

厄贝沙坦氢氯噻嗪片

Trade Name

安博诺

Brand Name

安博诺

Dosage Form

片剂

Strength

150mg/12.5mg

Drug Type

化学药品

Registration Date

July 9, 2020

Company Address

54 rue La Boétie, 75008 Paris, France

Company Address

1 rue de la Vierge, Ambares & Lagrave,F-33565 Carbon Blanc Cedex, France

Empowering clinical research with data-driven insights and AI-powered tools.